KK
Karunakar Kotian Bhoja
About Karunakar Kotian Bhoja
Data last updated:
Karunakar Kotian Bhoja has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Myeliyon Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Myeliyon Pharmaceutical Private Limited at ₹21.4 Lakh (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Myeliyon Pharmaceutical Private Limited U24299MH2018PTC316442 | Director | 27 Oct 2018 | 2018 | ₹21.4 Lakh (FY 2021) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Karunakar Kotian Bhoja
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karunakar Kotian Bhoja
Karunakar Kotian Bhoja has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Myeliyon Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Myeliyon Pharmaceutical Private Limited at ₹21.4 Lakh (FY 2021).
Karunakar Kotian Bhoja is associated with 1 company as Director, including Myeliyon Pharmaceutical Private Limited (₹21.4 Lakh).
Karunakar Kotian Bhoja has expertise in General Business.
Karunakar Kotian Bhoja has 7 years in corporate governance.
By reported revenue, the largest current company of Karunakar Kotian Bhoja is Myeliyon Pharmaceutical Private Limited, with revenue of ₹21.4 Lakh (FY 2021).
Karunakar Kotian Bhoja currently holds positions at 1 company: Myeliyon Pharmaceutical Private Limited (₹21.4 Lakh).